| 1. |
- Buchanan, E. M., et al.
(author)
-
The Psychological Science Accelerator's COVID-19 rapid-response dataset
- 2023
-
In: Scientific Data. - : Springer Science and Business Media LLC. - 2052-4463. ; 10:1
-
Journal article (peer-reviewed)abstract
- In response to the COVID-19 pandemic, the Psychological Science Accelerator coordinated three large-scale psychological studies to examine the effects of loss-gain framing, cognitive reappraisals, and autonomy framing manipulations on behavioral intentions and affective measures. The data collected (April to October 2020) included specific measures for each experimental study, a general questionnaire examining health prevention behaviors and COVID-19 experience, geographical and cultural context characterization, and demographic information for each participant. Each participant started the study with the same general questions and then was randomized to complete either one longer experiment or two shorter experiments. Data were provided by 73,223 participants with varying completion rates. Participants completed the survey from 111 geopolitical regions in 44 unique languages/dialects. The anonymized dataset described here is provided in both raw and processed formats to facilitate re-use and further analyses. The dataset offers secondary analytic opportunities to explore coping, framing, and self-determination across a diverse, global sample obtained at the onset of the COVID-19 pandemic, which can be merged with other time-sampled or geographic data.
|
|
| 2. |
- Yasunaka, S., et al.
(author)
-
Mapping of the air-sea CO2 flux in the Arctic Ocean and its adjacent seas: Basin-wide distribution and seasonal to interannual variability
- 2016
-
In: Polar Science. - : Elsevier BV. - 1873-9652. ; 10:3, s. 323-334
-
Journal article (peer-reviewed)abstract
- We produced 204 monthly maps of the air-sea CO2 flux in the Arctic north of 60 degrees N, including the Arctic Ocean and its adjacent seas, from January 1997 to December 2013 by using a self-organizing map technique. The partial pressure of CO2 (pCO(2)) in surface water data were obtained by shipboard underway measurements or calculated from alkalinity and total inorganic carbon of surface water samples. Subsequently, we investigated the basin-wide distribution and seasonal to interannual variability of the CO2 fluxes. The 17-year annual mean CO2 flux shows that all areas of the Arctic Ocean and its adjacent seas were net CO2 sinks. The estimated annual CO2 uptake by the Arctic Ocean was 180 TgC yr(-1). The CO2 influx was strongest in winter in the Greenland/Norwegian Seas (>15 mmol m(-2) day(-1)) and the Barents Sea (>12 mmol m(-2) day(-1)) because of strong winds, and strongest in summer in the Chukchi Sea (similar to 10 mmol m(-2) day(-1)) because of the sea-ice retreat In recent years, the CO2 uptake has increased in the Greenland/Norwegian Sea and decreased in the southern Barents Sea, owing to increased and decreased air-sea pCO(2) differences, respectively. (C) 2016 The Authors. Published by Elsevier B.V.
|
|
| 3. |
- Nagao-Kitamoto, H., et al.
(author)
-
Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota
- 2020
-
In: Nature Medicine. - : Springer Science and Business Media LLC. - 1078-8956 .- 1546-170X. ; 26, s. 608-617
-
Journal article (peer-reviewed)abstract
- In germ-free mice colonized with human microbiota, mucosal IL-22 signaling promotes the growth of succinate-consuming commensal bacteria via host mucus glycosylation, and transplantation of these bacteria limits Clostridioides difficile infection. The involvement of host immunity in the gut microbiota-mediated colonization resistance to Clostridioides difficile infection (CDI) is incompletely understood. Here, we show that interleukin (IL)-22, induced by colonization of the gut microbiota, is crucial for the prevention of CDI in human microbiota-associated (HMA) mice. IL-22 signaling in HMA mice regulated host glycosylation, which enabled the growth of succinate-consuming bacteria Phascolarctobacterium spp. within the gut microbiome. Phascolarctobacterium reduced the availability of luminal succinate, a crucial metabolite for the growth of C. difficile, and therefore prevented the growth of C. difficile. IL-22-mediated host N-glycosylation is likely impaired in patients with ulcerative colitis (UC) and renders UC-HMA mice more susceptible to CDI. Transplantation of healthy human-derived microbiota or Phascolarctobacterium reduced luminal succinate levels and restored colonization resistance in UC-HMA mice. IL-22-mediated host glycosylation thus fosters the growth of commensal bacteria that compete with C. difficile for the nutritional niche.
|
|
